CREDIT AGRICOLE SA : Notice of stabilization transactions MedinCell
05 Novembre 2018 - 6:30PM
Notice of
stabilization transactions
Paris, 5 November 2018
This document may
not be published, distributed or circulated, either directly or
indirectly, in the United States, Canada, Japan or
Australia
Crédit Agricole Corporate and
Investment Bank, acting as stabilizing manager in the context of
the initial public offering of MedinCell, announces that it
performed between 29 October and 2 November 2018 (included) on the
regulated market of Euronext Paris the following buying
stabilization transactions:
Date/time
of the transaction |
Unit price
(in EUR) |
Quantity |
2018-11-01 17:21:19 |
6.950000 |
24 |
2018-11-01 17:28:19 |
6.950000 |
76 |
2018-11-01 17:28:19 |
6.950000 |
4 |
2018-11-01 17:29:39 |
6.950000 |
6 |
2018-11-02 09:05:07 |
6.950000 |
94 |
2018-11-02 09:05:07 |
6.950000 |
110 |
2018-11-02 09:05:07 |
6.950000 |
1853 |
No communication or other
information related to this transaction or to MedinCell may be
transmitted to the public in a country in which any approval or
registration is required. No steps to such end have been taken or
will be taken by the Company in any country in which such steps
would be required (other than France).
This press release does not
constitute an offer or a solicitation to sell or subscribe
requiring a prospectus within the meaning of Directive 2003/71/EC
of the European Parliament and Council dated 4 November 2003, as
amended (the "Prospectus Directive").
With respect to the member states
of the European Economic Area other than France (the "Member
States") having implemented the Prospectus Directive into law, no
action has been or will be taken in order to permit a public offer
of the securities which would require the publication of a
prospectus in one of such Member States. As a result, the
securities of MedinCell may not and will not be offered in any
Member State other than France, except in accordance with the
exemptions set forth in Article 3 of the Prospectus Directive.
This press release must not be
published, released or distributed, directly or indirectly, in the
United States, Australia, Canada or Japan. This press release and
the information contained herein do not constitute an offer to sell
or subscribe, nor the solicitation of an order to purchase or
subscribe, securities in such countries.
This press release does not
constitute or form part of an offer of securities or a solicitation
for purchase, subscription or sale of securities in the United
States. Securities may not be offered, subscribed or sold in the
United States without registration under the U.S. Securities Act of
1933, as amended (the "U.S. Securities Act",) and other applicable
state securities law, except pursuant to an exemption from
registration. MedinCell shares have not been and will not be
registered under the U.S. Securities Act, and MedinCell does not
intend to undertake a public offering of its securities in the
United States.
This press release is not an
invitation nor an inducement to engage in investment activity for
the purpose of Section 21 of the Financial Services and Markets Act
2000, as amended ("FSMA"). This press release is directed only at
(i) persons outside the United Kingdom, (ii) investment
professionals falling within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (the
"Order"), (iii) persons referred to in Article 49(2)(a) to (d) of
the Order (high net worth entities, non-registered associations,
etc.) and (iv) other persons to whom this document may be lawfully
communicated (all persons listed in (i), (ii), (iii) and (iv) above
being referred to as "Relevant Persons"). The securities of
MedinCell described herein are available only to, and any
invitation, offer or agreement to subscribe, purchase or otherwise
acquire such securities will be engaged in only with Relevant
Persons. Any person who is not a Relevant Person must not act or
rely on this document or any of its contents.
The release, publication or
distribution of this press release in certain jurisdictions may be
restricted by laws or regulations. Persons in such jurisdictions
into which this press release is released, published or distributed
must inform themselves about and comply with such laws or
regulations.
Crédit Agricole Corporate and
Investment Bank, acting as Stabilization Agent, may, for a period
of 30 days following the date of public disclosure of the offering
price (i.e., according to the indicative time schedule, to November
2, 2018 inclusive) (but not under any circumstances), in accordance
with the applicable laws and regulations, in particular those of
Delegated Regulation No 2016/1052 of the European Commission of
March 8, 2016 supplementing Regulation (EU) No 596/2014 of the
European Parliament European Union and the Council and concerning
the conditions applicable to buyback programs and stabilization
measures, carry out stabilization operations in order to stabilize
or support the price of MedinCell shares on the regulated market of
Euronext Paris. In accordance with Article 7 of Delegated
Regulation No 2016/1052 of the European Commission of March 8,
2016, stabilization operations may not be carried out at a price
higher than the offer price. Such interventions may affect the
price of the shares and may result in the determination of a higher
market price than would otherwise prevail. Even if stabilization
operations were carried out, Crédit Agricole Corporate and
Investment Bank could, at any time, decide to discontinue such
operations. The information will be provided to the competent
market authorities and to the public in accordance with Article 6
of the abovementioned Regulation. Pursuant to the provisions of
Article 8 of the abovementioned Regulation, Crédit Agricole
Corporate and Investment Bank, acting on behalf of the
underwriters, may make over-allotments in connection with the offer
up to the number of shares covered by the over-allotment option,
plus, if applicable, 5% of the offer (excluding exercise of the
over-allotment option).
Notice of stabilization
transactions MedinCell
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: CREDIT AGRICOLE SA via Globenewswire
Grafico Azioni Credit Agricole (EU:ACA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Credit Agricole (EU:ACA)
Storico
Da Apr 2023 a Apr 2024